{"gene":"ECSIT","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1999,"finding":"ECSIT is a cytosolic adaptor protein that bridges TRAF6 to MEKK-1 in the Toll/IL-1 signaling pathway, and acts as a regulator of MEKK-1 processing; wild-type ECSIT accelerates MEKK-1 processing while a dominant-negative fragment blocks MEKK-1 processing and NF-κB activation.","method":"Co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — foundational study with reciprocal interaction data and dominant-negative functional validation, highly cited and replicated","pmids":["10465784"],"is_preprint":false},{"year":2007,"finding":"ECSIT localizes to mitochondria via an N-terminal targeting signal, where it interacts with the assembly chaperone NDUFAF1 in 500–850 kDa complexes; RNAi knockdown of ECSIT severely impairs mitochondrial complex I assembly and function.","method":"Affinity purification, reciprocal RNAi knockdowns, subcellular fractionation, blue native PAGE","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — affinity purification with reciprocal RNAi in two directions, multiple orthogonal methods in a single study","pmids":["17344420"],"is_preprint":false},{"year":2003,"finding":"ECSIT is essential for BMP signaling during mouse embryogenesis; it constitutively associates with Smad4 and associates with Smad1 in a BMP-inducible manner, and together with Smad1/Smad4 binds to the promoters of specific BMP target genes.","method":"Targeted null mutation (knockout mouse), co-immunoprecipitation, chromatin immunoprecipitation, shRNA knockdown","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — genetic knockout combined with biochemical co-IP and ChIP, multiple orthogonal methods","pmids":["14633973"],"is_preprint":false},{"year":2014,"finding":"Upon LPS stimulation, ECSIT forms a high-molecular-weight endogenous complex with TAK1 and TRAF6; ECSIT interacts with each protein and regulates TAK1 activity to activate NF-κB, and ECSIT mutants lacking specific interaction domains for TAK1 or TRAF6 cannot restore NF-κB activation.","method":"Co-immunoprecipitation of endogenous proteins, shRNA knockdown, domain-deletion mutagenesis, NF-κB reporter assays, cytokine measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — endogenous complex co-IP, domain mutagenesis, and functional rescue experiments","pmids":["25371197"],"is_preprint":false},{"year":2014,"finding":"ECSIT ubiquitination at lysine 372 (K372) is required for its interaction with p65/p50 NF-κB proteins and their nuclear colocalization; K372A mutant ECSIT fails to interact with NF-κB subunits and cannot restore NF-κB DNA-binding activity or cytokine production in ECSIT-knockdown cells.","method":"Co-immunoprecipitation, site-directed mutagenesis (K372A), nuclear fractionation, NF-κB DNA-binding assay, shRNA knockdown rescue","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — site-directed mutagenesis identifying specific lysine, combined with functional rescue and nuclear localization data","pmids":["25355951"],"is_preprint":false},{"year":2018,"finding":"ECSIT deletion in macrophages causes complete disruption of complex I activity, loss of the CI holoenzyme and multiple subassemblies, shifts metabolism to glycolysis, and causes defective mitophagy; ECSIT associates with the mitophagy regulator PINK1 and undergoes Parkin-dependent ubiquitination.","method":"Conditional knockout mouse, Seahorse metabolic flux, blue native PAGE for complex assembly, co-immunoprecipitation with PINK1, ubiquitination assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — conditional knockout with multiple orthogonal readouts (metabolic, biochemical, mitophagy)","pmids":["29514094"],"is_preprint":false},{"year":2012,"finding":"TRIM59 interacts with ECSIT as an adaptor protein in the TLR signaling pathway and negatively regulates NF-κB and IRF-3/7-mediated signaling; TRIM59 overexpression inhibits phosphorylation and dimerization of IRF3 and IRF7.","method":"Co-immunoprecipitation, luciferase reporter assay, shRNA knockdown, phosphorylation/dimerization analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, co-IP and reporter assay without full mechanistic reconstitution","pmids":["22588174"],"is_preprint":false},{"year":2014,"finding":"ECSIT acts as an essential scaffolding protein bridging RIG-I and MDA5 to VISA (MAVS) on mitochondria, mediating virus-triggered type I IFN induction; overexpression potentiated IRF3 activation and IFNB1 expression, while knockdown impaired antiviral responses.","method":"Co-immunoprecipitation, overexpression, shRNA knockdown, IRF3 activation assay, IFNB1 expression analysis","journal":"Journal of innate immunity","confidence":"Medium","confidence_rationale":"Tier 3 — single lab with co-IP and gain/loss-of-function but no structural or in vitro reconstitution","pmids":["25228397"],"is_preprint":false},{"year":2017,"finding":"Peroxiredoxin-6 (Prdx6) competitively interacts with ECSIT for TRAF6 binding via TRAF6's C-terminal TRAF-C domain, thereby disrupting the TRAF6-ECSIT complex and suppressing TLR4-induced mROS production and NF-κB activation.","method":"Co-immunoprecipitation, competitive binding assay, shRNA knockdown, mitochondrial ROS measurement, NF-κB reporter assay","journal":"Frontiers in cellular and infection microbiology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, competitive co-IP with functional readouts but no in vitro reconstitution","pmids":["28393051"],"is_preprint":false},{"year":2018,"finding":"The ECSIT V140A mutation increases ECSIT's affinity for the S100A8/S100A9 heterodimer, leading to potentiated NF-κB activation and increased NADPH oxidase activity, triggering hyperinflammation in extranodal NK/T cell lymphoma.","method":"Exome sequencing, knock-in mouse model, co-immunoprecipitation, NADPH oxidase activity assay, NF-κB reporter assay, xenograft mouse model","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including knock-in mouse, protein interaction studies, and functional assays in primary cells and xenografts","pmids":["29291352"],"is_preprint":false},{"year":2019,"finding":"Cereblon (CRBN) disrupts the ECSIT-TRAF6 complex by interacting with ECSIT, thereby inhibiting TRAF6-induced ubiquitination of ECSIT and suppressing mROS production and bactericidal activity following TLR4 stimulation.","method":"Co-immunoprecipitation, ubiquitination assay, shRNA/CRISPR knockdown/knockout, mitochondrial ROS measurement, bacterial survival assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, co-IP-based mechanism with functional validation","pmids":["31620128"],"is_preprint":false},{"year":2019,"finding":"p62 interacts with the internal domain of ECSIT, competitively inhibiting TRAF6-ECSIT complex formation and attenuating ECSIT ubiquitination, thereby negatively regulating TLR4-mediated NF-κB activation.","method":"Co-immunoprecipitation, p62 knockout MEF cells, ubiquitination assay, NF-κB activation assay, in vivo LPS challenge","journal":"Immune network","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, competitive co-IP with genetic knockout validation","pmids":["31281713"],"is_preprint":false},{"year":2021,"finding":"Human ECSIT is highly labile compared to murine ECSIT; low-level human ECSIT expression leads to reduced complex I assembly and activity, impaired oxidative phosphorylation, reduced ATP production, and severe cardiac hypertrophy with impaired mitophagy in aging humanized mice.","method":"Humanized knock-in mouse, Seahorse metabolic flux, complex I activity assay, mitochondrial fractionation, mitophagy assay, cardiomyocyte-specific conditional knockout","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model (humanized mouse + CKO) with multiple functional readouts","pmids":["34032637"],"is_preprint":false},{"year":2023,"finding":"An ENU-induced N209I mutation in ECSIT causes tissue-specific defects in complex I assembly, with profound effects in heart tissue (loss of CI expression and assembly, hypertrophic cardiomyopathy) but not in other tissues, revealing tissue-specific requirements for ECSIT in complex I assembly.","method":"ENU mutagenesis mouse model, Seahorse extracellular flux, blue native PAGE, biochemical CI activity assay, histology","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 — in vivo point mutation with multiple biochemical and functional readouts across tissues","pmids":["37395010"],"is_preprint":false},{"year":2023,"finding":"ECSIT promotes RANKL-induced mitochondrial stimulation in osteoclasts via TRAF6 interaction and mitochondrial localization; RANKL promotes ECSIT-TRAF6 interaction and ECSIT mitochondrial translocation, while estradiol abrogates these effects; ECSIT silencing abolishes estrogen's anti-osteoclastogenic effects.","method":"Co-immunoprecipitation, subcellular fractionation, shRNA knockdown, Seahorse metabolic flux, complex I activity assay, ROS measurement, osteoclast differentiation assay","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in primary cells, but single lab","pmids":["37152948"],"is_preprint":false},{"year":2023,"finding":"ECSIT loss in intestinal epithelium leads to metabolic reprogramming toward amino acid-based metabolism, demethylation and upregulation of eIF4F pathway genes, enhanced YAP protein translation, and transformation of intestinal cells to stem-like cells promoting tumorigenesis.","method":"Intestinal cell-specific ECSIT knockout mouse, metabolomics, methylation analysis, polysome profiling, Western blot, intestinal organoids","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with metabolomics and translational control readouts, single lab","pmids":["37409430"],"is_preprint":false},{"year":2024,"finding":"ECSIT mediates memory CD8+ T cell differentiation by controlling fumarate synthesis; ECSIT ablation in T cells causes loss of fumarate, leading to KDM5-mediated demethylation of the TCF-1 promoter and abrogation of TCF-1 expression, impairing memory CD8+ T cell development.","method":"T cell-specific ECSIT knockout, metabolomics (fumarate measurement), ChIP/methylation analysis, viral infection model, tumor models","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — cell-type specific genetic knockout with metabolomic and epigenetic mechanistic data, in vivo validation","pmids":["38326554"],"is_preprint":false},{"year":2025,"finding":"A 42-kDa ECSIT isoform (ECSIT-X4) localizes to mitochondria of adult cardiomyocytes and interacts with STAT3, increasing mitochondrial STAT3 levels and serine 727 phosphorylation, thereby promoting mitochondrial bioenergetics and protecting against pressure overload-induced cardiac hypertrophy.","method":"AAV9-mediated gene therapy, cardiomyocyte-specific knockout mouse, co-immunoprecipitation with STAT3, mitochondrial fractionation, Seahorse metabolic flux, TAC surgical model","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo cardiac model with co-IP and functional rescue, single lab","pmids":["39746855"],"is_preprint":false},{"year":2014,"finding":"Hepatitis B virus X protein (HBx) augments IL-1β-induced NF-κB activation by directly interacting with ECSIT (via HBx aa 51-80); co-expression of HBx and ECSIT increases IKK and IκB phosphorylation, and ECSIT knockdown abolishes this augmentation.","method":"GST pulldown, co-immunoprecipitation, CytoTrap two-hybrid, deletion mutagenesis, siRNA knockdown, NF-κB reporter assay","journal":"Virus research","confidence":"Medium","confidence_rationale":"Tier 3 — GST pulldown and co-IP with deletion mapping, functional NF-κB assays, single lab","pmids":["25449573"],"is_preprint":false},{"year":2026,"finding":"Mitochondria-targeted ECSIT overexpression promotes localization of the deubiquitinase OTUD3 to mitochondria; OTUD3 then stabilizes SIRT3 via deubiquitination, inhibiting mitochondrial DNA oxidation and alleviating metabolic disorders in MASH.","method":"Mitochondria-targeted ECSIT transgenic mice, co-immunoprecipitation, deubiquitination assay, HFHC/MCD diet MASH models, mitochondrial fractionation","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic model with biochemical pathway dissection, single lab, recent publication","pmids":["41640247"],"is_preprint":false},{"year":2025,"finding":"Mycobacterium tuberculosis HBHA virulence factor binds directly to ECSIT, disrupting the ECSIT-TRAF6 complex and inhibiting ECSIT ubiquitination in BCG-infected macrophages, thereby suppressing autophagy and promoting intracellular mycobacterial persistence; ECSIT deficiency abolishes HBHA-mediated autophagy suppression.","method":"Direct binding assay, co-immunoprecipitation, ECSIT knockdown (RAW264.7), LC3-II/Beclin-1 autophagy assay, intracellular bacterial survival assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 3 — direct binding and co-IP with genetic knockdown and functional autophagy/bacterial survival readouts, single lab","pmids":["41209015"],"is_preprint":false},{"year":2026,"finding":"ECSIT stabilizes the β-catenin complex and sustains Wnt signaling, regulating Lgr5+ intestinal stem cell proliferation and differentiation; intestinal epithelium-specific ECSIT knockout reduces β-catenin nuclear translocation and Lgr5 stem cell numbers, worsening chemotherapy-induced intestinal mucositis.","method":"Intestinal epithelium-specific ECSIT knockout mouse, Lgr5-specific inducible knockout, single-cell RNA-seq, β-catenin nuclear fractionation, ECSIT complementation rescue","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with scRNA-seq and rescue experiments, single lab, recent publication","pmids":["41611204"],"is_preprint":false}],"current_model":"ECSIT is a multifunctional adaptor/scaffold protein that operates in at least three compartments: in the cytosol it bridges TRAF6 to MEKK-1 and forms a TAK1-ECSIT-TRAF6 complex to activate NF-κB downstream of TLR/IL-1 receptors, undergoes TRAF6-dependent K372 ubiquitination required for nuclear NF-κB interaction, and scaffolds RIG-I/MDA5 to MAVS for antiviral IFN induction; in mitochondria (directed by an N-terminal targeting sequence) it interacts with NDUFAF1 to facilitate complex I assembly and mROS production that supports bactericidal activity, links to PINK1/Parkin-dependent mitophagy, mediates fumarate synthesis to control CD8+ T cell memory via epigenetic regulation, and interacts with STAT3 to promote mitochondrial bioenergetics; and in the nucleus it acts as a Smad1/Smad4 co-factor for BMP target gene transcription, essential for mesoderm formation during embryogenesis."},"narrative":{"teleology":[{"year":1999,"claim":"Identifying ECSIT as the missing link between TRAF6 and MEKK-1 established how TLR/IL-1 receptor signals reach the NF-κB cascade through a dedicated adaptor protein.","evidence":"Co-IP and dominant-negative overexpression with NF-κB reporter assays in mammalian cells","pmids":["10465784"],"confidence":"High","gaps":["No structural basis for the TRAF6-ECSIT-MEKK-1 interaction","In vivo requirement for NF-κB signaling not tested"]},{"year":2003,"claim":"Demonstrating that ECSIT knockout mice fail to form mesoderm and that ECSIT associates with Smad1/Smad4 on BMP target promoters revealed a second, transcription-regulatory function independent of its innate immune role.","evidence":"ECSIT-null mouse, co-IP, and ChIP at BMP target gene promoters","pmids":["14633973"],"confidence":"High","gaps":["How ECSIT switches between cytosolic signaling and nuclear cofactor roles is unknown","Whether ECSIT's BMP function persists in adult tissues beyond embryogenesis is untested"]},{"year":2007,"claim":"Discovery that ECSIT localizes to mitochondria via an N-terminal signal and partners with NDUFAF1 for complex I assembly redefined ECSIT as a mitochondrial biogenesis factor, not solely a signaling adaptor.","evidence":"Affinity purification, reciprocal RNAi, subcellular fractionation, and blue native PAGE","pmids":["17344420"],"confidence":"High","gaps":["Precise step in complex I assembly pathway where ECSIT acts was not defined","Relationship between ECSIT's signaling and mitochondrial functions not clarified"]},{"year":2014,"claim":"Mapping the endogenous TAK1-ECSIT-TRAF6 complex and showing that K372 ubiquitination of ECSIT is required for NF-κB nuclear interaction resolved how ECSIT's post-translational modification couples upstream signaling to transcription factor activation.","evidence":"Endogenous co-IP, domain-deletion mutagenesis, K372A site-directed mutagenesis, nuclear fractionation, and knockdown-rescue in multiple studies","pmids":["25371197","25355951"],"confidence":"High","gaps":["E3 ligase responsible for K372 ubiquitination not definitively identified in these studies","Whether K372 ubiquitination also affects mitochondrial ECSIT functions is unknown"]},{"year":2014,"claim":"Showing that ECSIT scaffolds RIG-I/MDA5 to MAVS extended ECSIT's innate immune role from TLR signaling to antiviral RLR-mediated type I interferon induction.","evidence":"Co-IP, overexpression, shRNA knockdown, IRF3 activation and IFNB1 expression assays","pmids":["25228397"],"confidence":"Medium","gaps":["No in vitro reconstitution of the RIG-I/MDA5-ECSIT-MAVS complex","Requirement not validated with genetic knockout"]},{"year":2018,"claim":"Conditional ECSIT knockout in macrophages showed that ECSIT is essential for complex I holoenzyme integrity, mROS-dependent bactericidal activity, and PINK1/Parkin-dependent mitophagy, unifying its mitochondrial assembly and innate immune functions.","evidence":"Myeloid-specific conditional knockout mouse, Seahorse metabolic flux, blue native PAGE, co-IP with PINK1, ubiquitination assays","pmids":["29514094"],"confidence":"High","gaps":["Whether ECSIT is a direct substrate of Parkin or ubiquitinated indirectly was not fully resolved","Mechanism linking complex I loss to mitophagy defects not delineated"]},{"year":2018,"claim":"The V140A gain-of-function mutation in NK/T cell lymphoma, which enhances ECSIT interaction with S100A8/S100A9 and hyperactivates NF-κB and NADPH oxidase, provided the first disease-linked ECSIT variant demonstrating pathological consequences of dysregulated ECSIT signaling.","evidence":"Exome sequencing, knock-in mouse, co-IP, NADPH oxidase and NF-κB assays, xenograft model","pmids":["29291352"],"confidence":"High","gaps":["Whether V140A affects mitochondrial complex I assembly is untested","Frequency and penetrance of ECSIT mutations across lymphoma subtypes not established"]},{"year":2017,"claim":"Identification of negative regulators—Prdx6, p62, and CRBN—that competitively disrupt the TRAF6-ECSIT complex defined a regulatory layer controlling ECSIT-dependent mROS production and NF-κB activation.","evidence":"Competitive co-IP, knockout MEFs, CRISPR knockout, ubiquitination assays, mROS and NF-κB functional readouts across multiple studies","pmids":["28393051","31281713","31620128"],"confidence":"Medium","gaps":["Relative physiological importance of Prdx6, p62, and CRBN in tuning ECSIT activity is unknown","No in vivo validation for Prdx6 or CRBN regulatory roles"]},{"year":2021,"claim":"Humanized ECSIT knock-in mice revealed that human ECSIT protein is far more labile than murine ECSIT, causing reduced complex I activity, impaired mitophagy, and cardiac hypertrophy with aging—establishing tissue-specific vulnerability to ECSIT dosage.","evidence":"Humanized knock-in mouse, cardiomyocyte-specific CKO, Seahorse, complex I assays, mitophagy assays","pmids":["34032637"],"confidence":"High","gaps":["Molecular basis for differential human vs. murine ECSIT protein stability is unresolved","Whether therapeutic stabilization of human ECSIT can rescue cardiac phenotype is untested"]},{"year":2023,"claim":"The N209I point mutation demonstrated that ECSIT requirements for complex I assembly are tissue-specific, with heart being most vulnerable, explaining cardiac hypertrophy as a primary manifestation of ECSIT deficiency.","evidence":"ENU mutagenesis mouse, blue native PAGE, Seahorse, CI activity assays across multiple tissues","pmids":["37395010"],"confidence":"High","gaps":["Why heart mitochondria are selectively dependent on ECSIT for CI assembly is mechanistically unexplained","No structural information on how N209I disrupts ECSIT function"]},{"year":2023,"claim":"Intestinal ECSIT loss causing metabolic reprogramming, eIF4F-YAP pathway activation, and stem cell transformation revealed an unexpected tumor-suppressive function through metabolic control of translational programs.","evidence":"Intestinal epithelium-specific ECSIT KO mouse, metabolomics, methylation analysis, polysome profiling, organoids","pmids":["37409430"],"confidence":"Medium","gaps":["Whether the tumorigenic effect is solely through complex I loss or involves signaling functions is unclear","No clinical validation in human colorectal cancer"]},{"year":2024,"claim":"Demonstrating that ECSIT controls fumarate synthesis to maintain H3K4me3 at the TCF-1 promoter via KDM5 regulation established a metabolite-to-epigenome axis through which mitochondrial ECSIT directs CD8+ T cell memory fate decisions.","evidence":"T cell-specific ECSIT KO, metabolomics, ChIP/methylation analysis, viral infection and tumor models in vivo","pmids":["38326554"],"confidence":"High","gaps":["Whether ECSIT directly catalyzes fumarate production or acts indirectly through complex I is not resolved","Applicability to human T cell immunotherapy not tested"]},{"year":2025,"claim":"Discovery that a 42-kDa ECSIT isoform (ECSIT-X4) interacts with mitochondrial STAT3 to promote its Ser727 phosphorylation and bioenergetic function identified a cardioprotective ECSIT-STAT3 axis and a therapeutic isoform for heart failure.","evidence":"AAV9 gene therapy, cardiomyocyte-specific KO, co-IP with STAT3, Seahorse, TAC pressure-overload model","pmids":["39746855"],"confidence":"Medium","gaps":["Kinase mediating STAT3 Ser727 phosphorylation downstream of ECSIT-X4 is unidentified","Whether ECSIT-X4 has distinct functions from full-length ECSIT beyond the heart is unknown"]},{"year":2025,"claim":"Mycobacterium tuberculosis HBHA directly binding ECSIT to disrupt TRAF6 interaction and suppress autophagy revealed ECSIT as a pathogen-targeted node for immune evasion.","evidence":"Direct binding assay, co-IP, ECSIT knockdown, autophagy markers, intracellular bacterial survival in RAW264.7 macrophages","pmids":["41209015"],"confidence":"Medium","gaps":["Not validated in primary human macrophages or in vivo infection models","Whether other mycobacterial factors also target ECSIT is unknown"]},{"year":2026,"claim":"Mitochondrial ECSIT overexpression recruiting OTUD3 to stabilize SIRT3 and showing that ECSIT sustains β-catenin/Wnt signaling in Lgr5+ intestinal stem cells expanded ECSIT's role to metabolic liver disease and intestinal homeostasis.","evidence":"Mito-targeted ECSIT transgenic mice with MASH models; intestinal epithelium-specific KO with scRNA-seq and β-catenin rescue","pmids":["41640247","41611204"],"confidence":"Medium","gaps":["Mechanism by which ECSIT recruits OTUD3 to mitochondria is not defined","Whether Wnt/β-catenin stabilization by ECSIT is direct or secondary to metabolic changes is unclear"]},{"year":null,"claim":"How ECSIT partitions between cytosolic, mitochondrial, and nuclear pools, what determines isoform-specific targeting, and how its dual signaling and bioenergetic functions are coordinated in different cell types remain major open questions.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of ECSIT or any of its complexes exists","Mechanism governing ECSIT partitioning among subcellular compartments is unknown","Whether ECSIT's BMP/Smad, NF-κB, and complex I functions are mutually exclusive or concurrent in single cells is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,3,7]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,3,4]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,5,12,13,17]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,3,4,7,8,10,11,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,9,21]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,5,12,13,16]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[5,20]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5]}],"complexes":["TAK1-ECSIT-TRAF6 complex","ECSIT-NDUFAF1 complex I assembly intermediate"],"partners":["TRAF6","NDUFAF1","SMAD1","SMAD4","TAK1","PINK1","STAT3","MAVS"],"other_free_text":[]},"mechanistic_narrative":"ECSIT is a multifunctional adaptor/scaffold protein that operates in cytosolic, mitochondrial, and nuclear compartments to integrate innate immune signaling, mitochondrial bioenergetics, and developmental transcription. In the cytosol, ECSIT bridges TRAF6 to MEKK-1 and TAK1, forming a signaling complex essential for TLR/IL-1-induced NF-κB activation, and undergoes K372 ubiquitination required for nuclear interaction with p65/p50 NF-κB subunits [PMID:10465784, PMID:25371197, PMID:25355951]; it also scaffolds RIG-I/MDA5 to MAVS for antiviral type I interferon induction [PMID:25228397]. In mitochondria, ECSIT interacts with NDUFAF1 to direct respiratory complex I assembly, associates with PINK1 to regulate Parkin-dependent mitophagy, controls fumarate-dependent epigenetic programming of CD8+ T cell memory via TCF-1 promoter methylation, and interacts with STAT3 to sustain oxidative phosphorylation in cardiomyocytes [PMID:17344420, PMID:29514094, PMID:38326554, PMID:39746855]. In the nucleus, ECSIT functions as a BMP-inducible cofactor that associates with Smad1/Smad4 to activate BMP target gene transcription essential for mesoderm formation during embryogenesis [PMID:14633973]."},"prefetch_data":{"uniprot":{"accession":"Q9BQ95","full_name":"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial","aliases":["Protein SITPEC"],"length_aa":431,"mass_kda":49.1,"function":"Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity) As part of the MCIA complex, involved in the assembly of the mitochondrial complex I","subcellular_location":"Cytoplasm; Nucleus; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9BQ95/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ECSIT","classification":"Not Classified","n_dependent_lines":148,"n_total_lines":1208,"dependency_fraction":0.12251655629139073},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ECSIT","total_profiled":1310},"omim":[{"mim_id":"616148","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 59; TRIM59","url":"https://www.omim.org/entry/616148"},{"mim_id":"615533","title":"TRANSMEMBRANE PROTEIN 126B; TMEM126B","url":"https://www.omim.org/entry/615533"},{"mim_id":"611126","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20","url":"https://www.omim.org/entry/611126"},{"mim_id":"608388","title":"ECSIT SIGNALING INTEGRATOR; ECSIT","url":"https://www.omim.org/entry/608388"},{"mim_id":"603030","title":"TOLL-LIKE RECEPTOR 4; TLR4","url":"https://www.omim.org/entry/603030"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ECSIT"},"hgnc":{"alias_symbol":["SITPEC"],"prev_symbol":[]},"alphafold":{"accession":"Q9BQ95","domains":[{"cath_id":"-","chopping":"213-250_261-312_354-399","consensus_level":"medium","plddt":88.7502,"start":213,"end":399},{"cath_id":"1.25.40","chopping":"70-209","consensus_level":"high","plddt":87.1247,"start":70,"end":209}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQ95","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ95-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ95-F1-predicted_aligned_error_v6.png","plddt_mean":71.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ECSIT","jax_strain_url":"https://www.jax.org/strain/search?query=ECSIT"},"sequence":{"accession":"Q9BQ95","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BQ95.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BQ95/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQ95"}},"corpus_meta":[{"pmid":"10465784","id":"PMC_10465784","title":"ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10465784","citation_count":257,"is_preprint":false},{"pmid":"17344420","id":"PMC_17344420","title":"Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17344420","citation_count":158,"is_preprint":false},{"pmid":"25371197","id":"PMC_25371197","title":"TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25371197","citation_count":86,"is_preprint":false},{"pmid":"22588174","id":"PMC_22588174","title":"TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22588174","citation_count":82,"is_preprint":false},{"pmid":"14633973","id":"PMC_14633973","title":"Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14633973","citation_count":78,"is_preprint":false},{"pmid":"29514094","id":"PMC_29514094","title":"An Essential Role for ECSIT in Mitochondrial Complex I Assembly and Mitophagy in Macrophages.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29514094","citation_count":71,"is_preprint":false},{"pmid":"29291352","id":"PMC_29291352","title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.","date":"2018","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29291352","citation_count":57,"is_preprint":false},{"pmid":"28393051","id":"PMC_28393051","title":"Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28393051","citation_count":39,"is_preprint":false},{"pmid":"22513506","id":"PMC_22513506","title":"Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.","date":"2012","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22513506","citation_count":35,"is_preprint":false},{"pmid":"25355951","id":"PMC_25355951","title":"Ubiquitination of ECSIT is crucial for the activation of p65/p50 NF-κBs in Toll-like receptor 4 signaling.","date":"2014","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/25355951","citation_count":30,"is_preprint":false},{"pmid":"25228397","id":"PMC_25228397","title":"ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses.","date":"2014","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25228397","citation_count":27,"is_preprint":false},{"pmid":"29288875","id":"PMC_29288875","title":"ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells.","date":"2017","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/29288875","citation_count":23,"is_preprint":false},{"pmid":"12762272","id":"PMC_12762272","title":"Diagnostic pathway of syncope and analysis of the impact of guidelines in a district general hospital. The ECSIT study (epidemiology and costs of syncope in Trento).","date":"2003","source":"Italian heart journal : official journal of the Italian Federation of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/12762272","citation_count":23,"is_preprint":false},{"pmid":"31620128","id":"PMC_31620128","title":"CRBN Is a Negative Regulator of Bactericidal Activity and Autophagy Activation Through Inhibiting the Ubiquitination of ECSIT and BECN1.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31620128","citation_count":22,"is_preprint":false},{"pmid":"24796866","id":"PMC_24796866","title":"Role of evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) in the antibacterial immunity of Marsupenaeus japonicus.","date":"2014","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24796866","citation_count":18,"is_preprint":false},{"pmid":"17187402","id":"PMC_17187402","title":"The nexus of iron and inflammation in hepcidin regulation: SMADs, STATs, and ECSIT.","date":"2007","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17187402","citation_count":17,"is_preprint":false},{"pmid":"31281713","id":"PMC_31281713","title":"p62 Negatively Regulates TLR4 Signaling via Functional Regulation of the TRAF6-ECSIT Complex.","date":"2019","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/31281713","citation_count":16,"is_preprint":false},{"pmid":"37152948","id":"PMC_37152948","title":"ECSIT is essential for RANKL-induced stimulation of mitochondria in osteoclasts and a target for the anti-osteoclastogenic effects of estrogens.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37152948","citation_count":14,"is_preprint":false},{"pmid":"25449573","id":"PMC_25449573","title":"Hepatitis B virus X protein increases the IL-1β-induced NF-κB activation via interaction with evolutionarily conserved signaling intermediate in Toll pathways (ECSIT).","date":"2014","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/25449573","citation_count":14,"is_preprint":false},{"pmid":"34032637","id":"PMC_34032637","title":"ECSIT is a critical limiting factor for cardiac function.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34032637","citation_count":14,"is_preprint":false},{"pmid":"38326554","id":"PMC_38326554","title":"ECSIT facilitates memory CD8+ T cell development by mediating fumarate synthesis during viral infection and tumorigenesis.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38326554","citation_count":13,"is_preprint":false},{"pmid":"35173723","id":"PMC_35173723","title":"The ECSIT Mediated Toll3-Dorsal-ALFs Pathway Inhibits Bacterial Amplification in Kuruma Shrimp.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35173723","citation_count":13,"is_preprint":false},{"pmid":"37409430","id":"PMC_37409430","title":"ECSIT Is a Critical Factor for Controlling Intestinal Homeostasis and Tumorigenesis through Regulating the Translation of YAP Protein.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37409430","citation_count":11,"is_preprint":false},{"pmid":"26204814","id":"PMC_26204814","title":"Identification and function of an evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) from Crassostrea hongkongensis.","date":"2015","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26204814","citation_count":11,"is_preprint":false},{"pmid":"39488037","id":"PMC_39488037","title":"ECSIT: Biological function and involvement in diseases.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39488037","citation_count":8,"is_preprint":false},{"pmid":"33238179","id":"PMC_33238179","title":"Identification, characterization, and functional analysis of Toll and ECSIT in Exopalaemon carinicauda.","date":"2020","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33238179","citation_count":8,"is_preprint":false},{"pmid":"37395010","id":"PMC_37395010","title":"Tissue-specific differences in the assembly of mitochondrial Complex I are revealed by a novel ENU mutation in ECSIT.","date":"2023","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/37395010","citation_count":7,"is_preprint":false},{"pmid":"36087818","id":"PMC_36087818","title":"Molecular characterization of the evolutionary conserved signaling intermediate in Toll pathways (ECSIT) of soiny mullet (Liza haematocheila).","date":"2022","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36087818","citation_count":6,"is_preprint":false},{"pmid":"39384444","id":"PMC_39384444","title":"Emerging roles of ECSIT in immunity and tumorigenesis.","date":"2024","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39384444","citation_count":5,"is_preprint":false},{"pmid":"26909903","id":"PMC_26909903","title":"Characterization, molecular cloning, and expression analysis of Ecsit in the spinyhead croaker, Collichthys lucidus.","date":"2016","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26909903","citation_count":5,"is_preprint":false},{"pmid":"39746855","id":"PMC_39746855","title":"ECSIT-X4 is Required for Preventing Pressure Overload-Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39746855","citation_count":5,"is_preprint":false},{"pmid":"35853181","id":"PMC_35853181","title":"Pleiotropic roles of evolutionarily conserved signaling intermediate in toll pathway (ECSIT) in pathophysiology.","date":"2022","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35853181","citation_count":4,"is_preprint":false},{"pmid":"35571656","id":"PMC_35571656","title":"ECSIT inhibits cell death to increase tumor progression and metastasis via p53 in human breast cancer.","date":"2022","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35571656","citation_count":3,"is_preprint":false},{"pmid":"37531975","id":"PMC_37531975","title":"Large-scale lysine crotonylation analysis reveals the role of TRAF6-Ecsit complex in endoplasmic reticulum stress in mud crab (Scylla paramamosain).","date":"2023","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37531975","citation_count":2,"is_preprint":false},{"pmid":"28251965","id":"PMC_28251965","title":"[Amphioxus ortholog of ECSIT, an evolutionarily conserved adaptor in the Toll and BMP signaling pathways].","date":"2017","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/28251965","citation_count":1,"is_preprint":false},{"pmid":"41640247","id":"PMC_41640247","title":"Targeted Mitochondrial ECSIT Overexpression Attenuates MASH by Increasing OTUD3 Expression.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41640247","citation_count":0,"is_preprint":false},{"pmid":"41611204","id":"PMC_41611204","title":"A protective role of ECSIT in chemotherapy-induced intestinal mucositis by maintaining Lgr5+ intestinal stem cells and gut homeostasis.","date":"2026","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41611204","citation_count":0,"is_preprint":false},{"pmid":"41209015","id":"PMC_41209015","title":"HBHA-ECSIT interaction disrupts macrophage autophagy to promote Mycobacterium tuberculosis persistence.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41209015","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.19.24314011","title":"Correspondence: Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma","date":"2024-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.19.24314011","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19804,"output_tokens":5120,"usd":0.068106},"stage2":{"model":"claude-opus-4-6","input_tokens":8728,"output_tokens":3950,"usd":0.213585},"total_usd":0.281691,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"ECSIT is a cytosolic adaptor protein that bridges TRAF6 to MEKK-1 in the Toll/IL-1 signaling pathway, and acts as a regulator of MEKK-1 processing; wild-type ECSIT accelerates MEKK-1 processing while a dominant-negative fragment blocks MEKK-1 processing and NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational study with reciprocal interaction data and dominant-negative functional validation, highly cited and replicated\",\n      \"pmids\": [\"10465784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ECSIT localizes to mitochondria via an N-terminal targeting signal, where it interacts with the assembly chaperone NDUFAF1 in 500–850 kDa complexes; RNAi knockdown of ECSIT severely impairs mitochondrial complex I assembly and function.\",\n      \"method\": \"Affinity purification, reciprocal RNAi knockdowns, subcellular fractionation, blue native PAGE\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — affinity purification with reciprocal RNAi in two directions, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"17344420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ECSIT is essential for BMP signaling during mouse embryogenesis; it constitutively associates with Smad4 and associates with Smad1 in a BMP-inducible manner, and together with Smad1/Smad4 binds to the promoters of specific BMP target genes.\",\n      \"method\": \"Targeted null mutation (knockout mouse), co-immunoprecipitation, chromatin immunoprecipitation, shRNA knockdown\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic knockout combined with biochemical co-IP and ChIP, multiple orthogonal methods\",\n      \"pmids\": [\"14633973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Upon LPS stimulation, ECSIT forms a high-molecular-weight endogenous complex with TAK1 and TRAF6; ECSIT interacts with each protein and regulates TAK1 activity to activate NF-κB, and ECSIT mutants lacking specific interaction domains for TAK1 or TRAF6 cannot restore NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins, shRNA knockdown, domain-deletion mutagenesis, NF-κB reporter assays, cytokine measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — endogenous complex co-IP, domain mutagenesis, and functional rescue experiments\",\n      \"pmids\": [\"25371197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECSIT ubiquitination at lysine 372 (K372) is required for its interaction with p65/p50 NF-κB proteins and their nuclear colocalization; K372A mutant ECSIT fails to interact with NF-κB subunits and cannot restore NF-κB DNA-binding activity or cytokine production in ECSIT-knockdown cells.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (K372A), nuclear fractionation, NF-κB DNA-binding assay, shRNA knockdown rescue\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — site-directed mutagenesis identifying specific lysine, combined with functional rescue and nuclear localization data\",\n      \"pmids\": [\"25355951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ECSIT deletion in macrophages causes complete disruption of complex I activity, loss of the CI holoenzyme and multiple subassemblies, shifts metabolism to glycolysis, and causes defective mitophagy; ECSIT associates with the mitophagy regulator PINK1 and undergoes Parkin-dependent ubiquitination.\",\n      \"method\": \"Conditional knockout mouse, Seahorse metabolic flux, blue native PAGE for complex assembly, co-immunoprecipitation with PINK1, ubiquitination assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout with multiple orthogonal readouts (metabolic, biochemical, mitophagy)\",\n      \"pmids\": [\"29514094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRIM59 interacts with ECSIT as an adaptor protein in the TLR signaling pathway and negatively regulates NF-κB and IRF-3/7-mediated signaling; TRIM59 overexpression inhibits phosphorylation and dimerization of IRF3 and IRF7.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, shRNA knockdown, phosphorylation/dimerization analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP and reporter assay without full mechanistic reconstitution\",\n      \"pmids\": [\"22588174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECSIT acts as an essential scaffolding protein bridging RIG-I and MDA5 to VISA (MAVS) on mitochondria, mediating virus-triggered type I IFN induction; overexpression potentiated IRF3 activation and IFNB1 expression, while knockdown impaired antiviral responses.\",\n      \"method\": \"Co-immunoprecipitation, overexpression, shRNA knockdown, IRF3 activation assay, IFNB1 expression analysis\",\n      \"journal\": \"Journal of innate immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab with co-IP and gain/loss-of-function but no structural or in vitro reconstitution\",\n      \"pmids\": [\"25228397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Peroxiredoxin-6 (Prdx6) competitively interacts with ECSIT for TRAF6 binding via TRAF6's C-terminal TRAF-C domain, thereby disrupting the TRAF6-ECSIT complex and suppressing TLR4-induced mROS production and NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, competitive binding assay, shRNA knockdown, mitochondrial ROS measurement, NF-κB reporter assay\",\n      \"journal\": \"Frontiers in cellular and infection microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, competitive co-IP with functional readouts but no in vitro reconstitution\",\n      \"pmids\": [\"28393051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The ECSIT V140A mutation increases ECSIT's affinity for the S100A8/S100A9 heterodimer, leading to potentiated NF-κB activation and increased NADPH oxidase activity, triggering hyperinflammation in extranodal NK/T cell lymphoma.\",\n      \"method\": \"Exome sequencing, knock-in mouse model, co-immunoprecipitation, NADPH oxidase activity assay, NF-κB reporter assay, xenograft mouse model\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including knock-in mouse, protein interaction studies, and functional assays in primary cells and xenografts\",\n      \"pmids\": [\"29291352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cereblon (CRBN) disrupts the ECSIT-TRAF6 complex by interacting with ECSIT, thereby inhibiting TRAF6-induced ubiquitination of ECSIT and suppressing mROS production and bactericidal activity following TLR4 stimulation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, shRNA/CRISPR knockdown/knockout, mitochondrial ROS measurement, bacterial survival assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP-based mechanism with functional validation\",\n      \"pmids\": [\"31620128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"p62 interacts with the internal domain of ECSIT, competitively inhibiting TRAF6-ECSIT complex formation and attenuating ECSIT ubiquitination, thereby negatively regulating TLR4-mediated NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, p62 knockout MEF cells, ubiquitination assay, NF-κB activation assay, in vivo LPS challenge\",\n      \"journal\": \"Immune network\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, competitive co-IP with genetic knockout validation\",\n      \"pmids\": [\"31281713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human ECSIT is highly labile compared to murine ECSIT; low-level human ECSIT expression leads to reduced complex I assembly and activity, impaired oxidative phosphorylation, reduced ATP production, and severe cardiac hypertrophy with impaired mitophagy in aging humanized mice.\",\n      \"method\": \"Humanized knock-in mouse, Seahorse metabolic flux, complex I activity assay, mitochondrial fractionation, mitophagy assay, cardiomyocyte-specific conditional knockout\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model (humanized mouse + CKO) with multiple functional readouts\",\n      \"pmids\": [\"34032637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"An ENU-induced N209I mutation in ECSIT causes tissue-specific defects in complex I assembly, with profound effects in heart tissue (loss of CI expression and assembly, hypertrophic cardiomyopathy) but not in other tissues, revealing tissue-specific requirements for ECSIT in complex I assembly.\",\n      \"method\": \"ENU mutagenesis mouse model, Seahorse extracellular flux, blue native PAGE, biochemical CI activity assay, histology\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo point mutation with multiple biochemical and functional readouts across tissues\",\n      \"pmids\": [\"37395010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ECSIT promotes RANKL-induced mitochondrial stimulation in osteoclasts via TRAF6 interaction and mitochondrial localization; RANKL promotes ECSIT-TRAF6 interaction and ECSIT mitochondrial translocation, while estradiol abrogates these effects; ECSIT silencing abolishes estrogen's anti-osteoclastogenic effects.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, shRNA knockdown, Seahorse metabolic flux, complex I activity assay, ROS measurement, osteoclast differentiation assay\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in primary cells, but single lab\",\n      \"pmids\": [\"37152948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ECSIT loss in intestinal epithelium leads to metabolic reprogramming toward amino acid-based metabolism, demethylation and upregulation of eIF4F pathway genes, enhanced YAP protein translation, and transformation of intestinal cells to stem-like cells promoting tumorigenesis.\",\n      \"method\": \"Intestinal cell-specific ECSIT knockout mouse, metabolomics, methylation analysis, polysome profiling, Western blot, intestinal organoids\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with metabolomics and translational control readouts, single lab\",\n      \"pmids\": [\"37409430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ECSIT mediates memory CD8+ T cell differentiation by controlling fumarate synthesis; ECSIT ablation in T cells causes loss of fumarate, leading to KDM5-mediated demethylation of the TCF-1 promoter and abrogation of TCF-1 expression, impairing memory CD8+ T cell development.\",\n      \"method\": \"T cell-specific ECSIT knockout, metabolomics (fumarate measurement), ChIP/methylation analysis, viral infection model, tumor models\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific genetic knockout with metabolomic and epigenetic mechanistic data, in vivo validation\",\n      \"pmids\": [\"38326554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A 42-kDa ECSIT isoform (ECSIT-X4) localizes to mitochondria of adult cardiomyocytes and interacts with STAT3, increasing mitochondrial STAT3 levels and serine 727 phosphorylation, thereby promoting mitochondrial bioenergetics and protecting against pressure overload-induced cardiac hypertrophy.\",\n      \"method\": \"AAV9-mediated gene therapy, cardiomyocyte-specific knockout mouse, co-immunoprecipitation with STAT3, mitochondrial fractionation, Seahorse metabolic flux, TAC surgical model\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo cardiac model with co-IP and functional rescue, single lab\",\n      \"pmids\": [\"39746855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hepatitis B virus X protein (HBx) augments IL-1β-induced NF-κB activation by directly interacting with ECSIT (via HBx aa 51-80); co-expression of HBx and ECSIT increases IKK and IκB phosphorylation, and ECSIT knockdown abolishes this augmentation.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, CytoTrap two-hybrid, deletion mutagenesis, siRNA knockdown, NF-κB reporter assay\",\n      \"journal\": \"Virus research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — GST pulldown and co-IP with deletion mapping, functional NF-κB assays, single lab\",\n      \"pmids\": [\"25449573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Mitochondria-targeted ECSIT overexpression promotes localization of the deubiquitinase OTUD3 to mitochondria; OTUD3 then stabilizes SIRT3 via deubiquitination, inhibiting mitochondrial DNA oxidation and alleviating metabolic disorders in MASH.\",\n      \"method\": \"Mitochondria-targeted ECSIT transgenic mice, co-immunoprecipitation, deubiquitination assay, HFHC/MCD diet MASH models, mitochondrial fractionation\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with biochemical pathway dissection, single lab, recent publication\",\n      \"pmids\": [\"41640247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mycobacterium tuberculosis HBHA virulence factor binds directly to ECSIT, disrupting the ECSIT-TRAF6 complex and inhibiting ECSIT ubiquitination in BCG-infected macrophages, thereby suppressing autophagy and promoting intracellular mycobacterial persistence; ECSIT deficiency abolishes HBHA-mediated autophagy suppression.\",\n      \"method\": \"Direct binding assay, co-immunoprecipitation, ECSIT knockdown (RAW264.7), LC3-II/Beclin-1 autophagy assay, intracellular bacterial survival assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct binding and co-IP with genetic knockdown and functional autophagy/bacterial survival readouts, single lab\",\n      \"pmids\": [\"41209015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ECSIT stabilizes the β-catenin complex and sustains Wnt signaling, regulating Lgr5+ intestinal stem cell proliferation and differentiation; intestinal epithelium-specific ECSIT knockout reduces β-catenin nuclear translocation and Lgr5 stem cell numbers, worsening chemotherapy-induced intestinal mucositis.\",\n      \"method\": \"Intestinal epithelium-specific ECSIT knockout mouse, Lgr5-specific inducible knockout, single-cell RNA-seq, β-catenin nuclear fractionation, ECSIT complementation rescue\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with scRNA-seq and rescue experiments, single lab, recent publication\",\n      \"pmids\": [\"41611204\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ECSIT is a multifunctional adaptor/scaffold protein that operates in at least three compartments: in the cytosol it bridges TRAF6 to MEKK-1 and forms a TAK1-ECSIT-TRAF6 complex to activate NF-κB downstream of TLR/IL-1 receptors, undergoes TRAF6-dependent K372 ubiquitination required for nuclear NF-κB interaction, and scaffolds RIG-I/MDA5 to MAVS for antiviral IFN induction; in mitochondria (directed by an N-terminal targeting sequence) it interacts with NDUFAF1 to facilitate complex I assembly and mROS production that supports bactericidal activity, links to PINK1/Parkin-dependent mitophagy, mediates fumarate synthesis to control CD8+ T cell memory via epigenetic regulation, and interacts with STAT3 to promote mitochondrial bioenergetics; and in the nucleus it acts as a Smad1/Smad4 co-factor for BMP target gene transcription, essential for mesoderm formation during embryogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ECSIT is a multifunctional adaptor/scaffold protein that operates in cytosolic, mitochondrial, and nuclear compartments to integrate innate immune signaling, mitochondrial bioenergetics, and developmental transcription. In the cytosol, ECSIT bridges TRAF6 to MEKK-1 and TAK1, forming a signaling complex essential for TLR/IL-1-induced NF-κB activation, and undergoes K372 ubiquitination required for nuclear interaction with p65/p50 NF-κB subunits [PMID:10465784, PMID:25371197, PMID:25355951]; it also scaffolds RIG-I/MDA5 to MAVS for antiviral type I interferon induction [PMID:25228397]. In mitochondria, ECSIT interacts with NDUFAF1 to direct respiratory complex I assembly, associates with PINK1 to regulate Parkin-dependent mitophagy, controls fumarate-dependent epigenetic programming of CD8+ T cell memory via TCF-1 promoter methylation, and interacts with STAT3 to sustain oxidative phosphorylation in cardiomyocytes [PMID:17344420, PMID:29514094, PMID:38326554, PMID:39746855]. In the nucleus, ECSIT functions as a BMP-inducible cofactor that associates with Smad1/Smad4 to activate BMP target gene transcription essential for mesoderm formation during embryogenesis [PMID:14633973].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying ECSIT as the missing link between TRAF6 and MEKK-1 established how TLR/IL-1 receptor signals reach the NF-κB cascade through a dedicated adaptor protein.\",\n      \"evidence\": \"Co-IP and dominant-negative overexpression with NF-κB reporter assays in mammalian cells\",\n      \"pmids\": [\"10465784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for the TRAF6-ECSIT-MEKK-1 interaction\", \"In vivo requirement for NF-κB signaling not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that ECSIT knockout mice fail to form mesoderm and that ECSIT associates with Smad1/Smad4 on BMP target promoters revealed a second, transcription-regulatory function independent of its innate immune role.\",\n      \"evidence\": \"ECSIT-null mouse, co-IP, and ChIP at BMP target gene promoters\",\n      \"pmids\": [\"14633973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ECSIT switches between cytosolic signaling and nuclear cofactor roles is unknown\", \"Whether ECSIT's BMP function persists in adult tissues beyond embryogenesis is untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that ECSIT localizes to mitochondria via an N-terminal signal and partners with NDUFAF1 for complex I assembly redefined ECSIT as a mitochondrial biogenesis factor, not solely a signaling adaptor.\",\n      \"evidence\": \"Affinity purification, reciprocal RNAi, subcellular fractionation, and blue native PAGE\",\n      \"pmids\": [\"17344420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise step in complex I assembly pathway where ECSIT acts was not defined\", \"Relationship between ECSIT's signaling and mitochondrial functions not clarified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapping the endogenous TAK1-ECSIT-TRAF6 complex and showing that K372 ubiquitination of ECSIT is required for NF-κB nuclear interaction resolved how ECSIT's post-translational modification couples upstream signaling to transcription factor activation.\",\n      \"evidence\": \"Endogenous co-IP, domain-deletion mutagenesis, K372A site-directed mutagenesis, nuclear fractionation, and knockdown-rescue in multiple studies\",\n      \"pmids\": [\"25371197\", \"25355951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible for K372 ubiquitination not definitively identified in these studies\", \"Whether K372 ubiquitination also affects mitochondrial ECSIT functions is unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that ECSIT scaffolds RIG-I/MDA5 to MAVS extended ECSIT's innate immune role from TLR signaling to antiviral RLR-mediated type I interferon induction.\",\n      \"evidence\": \"Co-IP, overexpression, shRNA knockdown, IRF3 activation and IFNB1 expression assays\",\n      \"pmids\": [\"25228397\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro reconstitution of the RIG-I/MDA5-ECSIT-MAVS complex\", \"Requirement not validated with genetic knockout\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Conditional ECSIT knockout in macrophages showed that ECSIT is essential for complex I holoenzyme integrity, mROS-dependent bactericidal activity, and PINK1/Parkin-dependent mitophagy, unifying its mitochondrial assembly and innate immune functions.\",\n      \"evidence\": \"Myeloid-specific conditional knockout mouse, Seahorse metabolic flux, blue native PAGE, co-IP with PINK1, ubiquitination assays\",\n      \"pmids\": [\"29514094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ECSIT is a direct substrate of Parkin or ubiquitinated indirectly was not fully resolved\", \"Mechanism linking complex I loss to mitophagy defects not delineated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The V140A gain-of-function mutation in NK/T cell lymphoma, which enhances ECSIT interaction with S100A8/S100A9 and hyperactivates NF-κB and NADPH oxidase, provided the first disease-linked ECSIT variant demonstrating pathological consequences of dysregulated ECSIT signaling.\",\n      \"evidence\": \"Exome sequencing, knock-in mouse, co-IP, NADPH oxidase and NF-κB assays, xenograft model\",\n      \"pmids\": [\"29291352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether V140A affects mitochondrial complex I assembly is untested\", \"Frequency and penetrance of ECSIT mutations across lymphoma subtypes not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of negative regulators—Prdx6, p62, and CRBN—that competitively disrupt the TRAF6-ECSIT complex defined a regulatory layer controlling ECSIT-dependent mROS production and NF-κB activation.\",\n      \"evidence\": \"Competitive co-IP, knockout MEFs, CRISPR knockout, ubiquitination assays, mROS and NF-κB functional readouts across multiple studies\",\n      \"pmids\": [\"28393051\", \"31281713\", \"31620128\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative physiological importance of Prdx6, p62, and CRBN in tuning ECSIT activity is unknown\", \"No in vivo validation for Prdx6 or CRBN regulatory roles\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Humanized ECSIT knock-in mice revealed that human ECSIT protein is far more labile than murine ECSIT, causing reduced complex I activity, impaired mitophagy, and cardiac hypertrophy with aging—establishing tissue-specific vulnerability to ECSIT dosage.\",\n      \"evidence\": \"Humanized knock-in mouse, cardiomyocyte-specific CKO, Seahorse, complex I assays, mitophagy assays\",\n      \"pmids\": [\"34032637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for differential human vs. murine ECSIT protein stability is unresolved\", \"Whether therapeutic stabilization of human ECSIT can rescue cardiac phenotype is untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The N209I point mutation demonstrated that ECSIT requirements for complex I assembly are tissue-specific, with heart being most vulnerable, explaining cardiac hypertrophy as a primary manifestation of ECSIT deficiency.\",\n      \"evidence\": \"ENU mutagenesis mouse, blue native PAGE, Seahorse, CI activity assays across multiple tissues\",\n      \"pmids\": [\"37395010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why heart mitochondria are selectively dependent on ECSIT for CI assembly is mechanistically unexplained\", \"No structural information on how N209I disrupts ECSIT function\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Intestinal ECSIT loss causing metabolic reprogramming, eIF4F-YAP pathway activation, and stem cell transformation revealed an unexpected tumor-suppressive function through metabolic control of translational programs.\",\n      \"evidence\": \"Intestinal epithelium-specific ECSIT KO mouse, metabolomics, methylation analysis, polysome profiling, organoids\",\n      \"pmids\": [\"37409430\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the tumorigenic effect is solely through complex I loss or involves signaling functions is unclear\", \"No clinical validation in human colorectal cancer\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that ECSIT controls fumarate synthesis to maintain H3K4me3 at the TCF-1 promoter via KDM5 regulation established a metabolite-to-epigenome axis through which mitochondrial ECSIT directs CD8+ T cell memory fate decisions.\",\n      \"evidence\": \"T cell-specific ECSIT KO, metabolomics, ChIP/methylation analysis, viral infection and tumor models in vivo\",\n      \"pmids\": [\"38326554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ECSIT directly catalyzes fumarate production or acts indirectly through complex I is not resolved\", \"Applicability to human T cell immunotherapy not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that a 42-kDa ECSIT isoform (ECSIT-X4) interacts with mitochondrial STAT3 to promote its Ser727 phosphorylation and bioenergetic function identified a cardioprotective ECSIT-STAT3 axis and a therapeutic isoform for heart failure.\",\n      \"evidence\": \"AAV9 gene therapy, cardiomyocyte-specific KO, co-IP with STAT3, Seahorse, TAC pressure-overload model\",\n      \"pmids\": [\"39746855\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase mediating STAT3 Ser727 phosphorylation downstream of ECSIT-X4 is unidentified\", \"Whether ECSIT-X4 has distinct functions from full-length ECSIT beyond the heart is unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mycobacterium tuberculosis HBHA directly binding ECSIT to disrupt TRAF6 interaction and suppress autophagy revealed ECSIT as a pathogen-targeted node for immune evasion.\",\n      \"evidence\": \"Direct binding assay, co-IP, ECSIT knockdown, autophagy markers, intracellular bacterial survival in RAW264.7 macrophages\",\n      \"pmids\": [\"41209015\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not validated in primary human macrophages or in vivo infection models\", \"Whether other mycobacterial factors also target ECSIT is unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Mitochondrial ECSIT overexpression recruiting OTUD3 to stabilize SIRT3 and showing that ECSIT sustains β-catenin/Wnt signaling in Lgr5+ intestinal stem cells expanded ECSIT's role to metabolic liver disease and intestinal homeostasis.\",\n      \"evidence\": \"Mito-targeted ECSIT transgenic mice with MASH models; intestinal epithelium-specific KO with scRNA-seq and β-catenin rescue\",\n      \"pmids\": [\"41640247\", \"41611204\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which ECSIT recruits OTUD3 to mitochondria is not defined\", \"Whether Wnt/β-catenin stabilization by ECSIT is direct or secondary to metabolic changes is unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ECSIT partitions between cytosolic, mitochondrial, and nuclear pools, what determines isoform-specific targeting, and how its dual signaling and bioenergetic functions are coordinated in different cell types remain major open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of ECSIT or any of its complexes exists\", \"Mechanism governing ECSIT partitioning among subcellular compartments is unknown\", \"Whether ECSIT's BMP/Smad, NF-κB, and complex I functions are mutually exclusive or concurrent in single cells is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3, 7]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 5, 12, 13, 17]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 3, 4, 7, 8, 10, 11, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 9, 21]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 5, 12, 13, 16]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5, 20]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\n      \"TAK1-ECSIT-TRAF6 complex\",\n      \"ECSIT-NDUFAF1 complex I assembly intermediate\"\n    ],\n    \"partners\": [\n      \"TRAF6\",\n      \"NDUFAF1\",\n      \"SMAD1\",\n      \"SMAD4\",\n      \"TAK1\",\n      \"PINK1\",\n      \"STAT3\",\n      \"MAVS\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}